A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
Clinical trial NCT04556773 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04556773
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2023-08-16
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.